CXCL9 and macrophage activation syndrome: Rodriguez-Smith et al. compared the levels of several serum inflammatory biomarkers of interest in patients with MIS-C, KD, and MAS, demonstrating that MIS-C, unlike KD, was characterized by higher serum levels of CXCL9, an important cytokine in the pathophysiology of MAS [17].